Scope: Create a drug delivery device for the eye.

Challenge: Develop a cost-effective device with a tactile and audible indication of dose increment, proper needle geometry and FDA certified

Outcome: Developed the first system in 2006 & completed a VAVE in 2012. PDV as manufactured more than 300,000 units of this product over 12 years.

 

A Doctor in Australia used the product off label in the 2010s to arrest and reverse blindness in a patient